Skip to main content
Contact Us
Subscriber Sign In
navigation
サイト内検索
What We Do
Commercial Intelligence
Products
Evaluate Pharma
Evaluate Omnium
Evaluate Medtech
Evaluate Epi
Japan Drug Forecasts
Europe Drug Forecasts
CDMO Intelligence
Pharma Consulting & Analytics
Pharma Consulting & Analytics
Data Feeds
Evaluate Vantage
News
Analysis
Policy & Pricing
Insights
Events
Medtech
Therapy Areas
Evaluate for Biotech
How We Can Help You
Pharma and Biotech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
Multimedia
Blog
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Contact Us
Sign Up for Evaluate Vantage
Talent
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
Breadcrumb
Home
Vantage
Pharmaceutical Companies
Cancer Vaccines
Evaluate
December 13, 2017
Aduro brushes off cancer vaccine stumble
November 17, 2017
Snippet roundup: Three approvals and more pricing headaches
October 26, 2017
SITC preview – All eyes on Incyte and Infinity
September 26, 2017
Buzzword du jour falls flat with Genocea investors
September 15, 2017
Prostvac’s glimmers of hope evaporate
July 11, 2017
Sanofi switches eggs for insects with vaccines move
June 01, 2017
Immuno-oncology combinations surge as sector seeks the fairy dust
April 06, 2017
Interview – Boehringer plays catch-up in immuno-oncology
March 07, 2017
Therapy focus – Early beginnings for Alzheimer’s vaccines
February 27, 2017
Therapy focus – against the odds, cancer vaccines plough on
Latest Reports
July 27, 2023
H1 Round Up: The haves and the have-nots
July 21, 2023
ADA/EASL eBook
Editor's Picks
July 03, 2023
Astrazeneca and Daiichi’s big reveal disappoints
July 13, 2023
Pharma finds a way to gain weight
July 03, 2023
Protagonist investors flake as psoriasis pill disappoints
June 29, 2023
Approaching datasets for big pharma
June 27, 2023
Nkarta goes back to basics